v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Net revenue $ 4,055,000 $ 1,881,000
Cost of revenues 1,750,000 1,053,000
Cost of revenues – amortization of acquired intangibles 7,000 88,000
Gross profit 2,298,000 740,000
Operating expenses:    
Research and development 15,900,000 9,839,000
Sales and marketing 6,343,000 3,944,000
General and administrative 10,633,000 10,204,000
Change in fair value of contingent consideration 5,946,000 (4,275,000)
Impairment losses 14,600,000 41,900,000
Impairment loss on held for sale assets 0 169,000
Total operating expenses 53,422,000 61,781,000
Loss from operations (51,124,000) (61,041,000)
Other (expenses) income:    
Interest expense (109,000) (84,000)
Other income, net 1,011,000 462,000
Total other income, net 902,000 378,000
Loss before income taxes (50,222,000) (60,663,000)
Income taxes 0 0
Net loss (50,222,000) (60,663,000)
Net loss per share (Note 2):    
Net loss attributable to common stockholders - basic (50,222,000) (60,926,000)
Net loss attributable to common stockholders - diluted $ (50,222,000) $ (60,926,000)
Net loss attributable to common stockholders per share - basic $ (1.65) $ (4.66)
Net loss attributable to common stockholders per share - diluted $ (1.65) $ (4.66)
Weighted average shares outstanding - basic 30,476 13,071
Weighted average shares outstanding - diluted 30,476 13,071